Journal of Vaccine Research 2024, Vol.14, No.4, 170-182 http://medscipublisher.com/index.php/jvr 182 Villar L., Dayan G., Arredondo-García J., Rivera D., Cunha R., Deseda C., Reynales H., Costa M., Morales-Ramirez J., Carrasquilla G., Rey L., Dietze R., Luz K., Rivas E., Montoya M., Supelano M., Zambrano B., Langevin E., Boaz M., Tornieporth N., Saville M., and Noriega F., 2015, Efficacy of a tetravalent dengue vaccine in children in latin america, New England Journal of Medicine, 372(2): 113-123. https://doi.org/10.1056/NEJMoa1411037 PMid:25365753 Walsh M.C.R., Alam M.S., Pierce K.K., Carmolli M., Alam M., Dickson D.M., Bak D.M., Afreen S., Nazib F., Golam K., Qadri F., Diehl S.A., Durbin A.P., Whitehead S.S., Haque R., and Kirkpatrick B.D., 2024, Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial, The Lancet Infectious Diseases, 24(2): 150-160. https://doi.org/10.1016/S1473-3099(23)00520-0 PMid:37776876 Webster D.P., Farrar J., and Rowland-Jones S., 2009, Progress towards a dengue vaccine, The Lancet Infectious Diseases, 9(11): 678-687. https://doi.org/10.1016/S1473-3099(09)70254-3 PMid:19850226 Wichmann O., Vannice K., Asturias E., Luna E., Longini I., Lopez A., Smith P., Tissera H., Yoon I., and Hombach J., 2017, Live-attenuated tetravalent dengue vaccines: The needs and challenges of post-licensure evaluation of vaccine safety and effectiveness, Vaccine, 35(42): 5535-5542. https://doi.org/10.1016/j.vaccine.2017.08.066 PMid:28893477 Wilder-Smith A., 2020, Dengue vaccine development: status and future, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 63(1): 40. https://doi.org/10.1007/s00103-019-03060-3 PMid:31784763 PMCid:PMC7224137 Xu L.H., Feng T.T., and Fang K.Y., 2024, Safety and efficacy of mRNA vaccines: insights from clinical trials, International Journal of Clinical Case Reports, 14(3): 117-131. https://dx.doi.org/10.5376/ijccr.2024.14.0014 Xu W., and Li J.H., 2024, Peptide-based vaccines for oral cancer: mechanisms of action and clinical outcomes, International Journal of Clinical Case Reports, 14(3): 132-143. https://dx.doi.org/10.5376/ijccr.2024.14.0015
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==